Skip to main content
SpringerLink
Log in

EMA harmonises product labels, revises contraindications

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMA.Questions and answers on Priorix (measles, mumps and rubella vaccine (live)) - Outcome of a procedure under Article 30 of Directive 2001/83/EC. Internet Document: [2 pages], 15 Mar 2012. Available from: URL: http://www.ema.europa.eu

  2. EMA.Questions and answers on Femara and associated names (letrozole, 2.5 mg tablets) - Outcome of a procedure under Article 30 of Directive 2001/83/EC. Internet Document: [2 pages], 15 Mar 2012. Available from: URL: http://www.ema.europa.eu

  3. EMA.Summary of opinion (post authorisation) - Ventavis. Internet Document: [2 pages], 15 Mar 2012. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

EMA harmonises product labels, revises contraindications. React. Wkly. 1397, 3 (2012). https://doi.org/10.2165/00128415-201213970-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213970-00008

Keywords

Search

Navigation